Dear All
Section 1.2 of this new guideline on 'myeloma: diagnosis and management' states 'use serum protein electrophoresis and serum-free light chain assay to confirm the presence of a paraprotein'. Should this be interpreted as: all myeloma screens should have serum electrophoresis and sFLC analysis? Or since most myeloma screens are negative is it not going that far given the use of the word 'confirm'. Perhaps it means sFLC should be done at least if an abnormality is detected in one of the other tests?
Best wishes,
Malcolm
Malcolm McTaggart
Senior Clinical Scientist
Biochemistry, Pathology
Shrewsbury and Telford Hospital NHS Trust
________________________________________
From: Clinical biochemistry discussion list [[log in to unmask]] On Behalf Of Phillip Monaghan [[log in to unmask]]
Sent: 02 March 2016 13:39
To: [log in to unmask]
Subject: Re: AKI
---
This message was sent from an email address external to NHSmail but gives the appearance of being from an NHSmail (@nhs.net) address. The recipient should verify the sender and content before acting upon information contained within.
The identified sender is [log in to unmask]
---
I have been pushing for a move to CKD-EPI at my Trust for some time now and have finally gained clinical approval through the relevant governance channels. We intend to move to CKD-EPI in line with our LIMS upgrade later in the year.
Note the recent statement from the ACB and LIMS manufacturers regarding CKD-EPI (issued 09th February 2016).
Phil
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical community working in clinical biochemistry.
Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
Green Laboratories Work
http://www.laboratorymedicine.nhs.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
********************************************************************************************************************
This message may contain confidential information. If you are not the intended recipient please inform the
sender that you have received the message in error before deleting it.
Please do not disclose, copy or distribute information in this e-mail or take any action in reliance on its contents:
to do so is strictly prohibited and may be unlawful.
Thank you for your co-operation.
NHSmail is the secure email and directory service available for all NHS staff in England and Scotland
NHSmail is approved for exchanging patient data and other sensitive information with NHSmail and GSi recipients
NHSmail provides an email address for your career in the NHS and can be accessed anywhere
********************************************************************************************************************
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical community working in clinical biochemistry.
Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
Green Laboratories Work
http://www.laboratorymedicine.nhs.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
|